blood plasma

CSL Behring

CSL earmarks $1.5B for US production expansion over next 5 years

The company will spend approximately $1.5 billion in capital investments to grow its U.S. plasma manufacturing capabilities over the next five years.

Zoey Becker Nov 18, 2025 7:56am

Graphic of a drop of blood made up of small data points and nodes

Grifols preps blood clot treatment approval push after ph. 3 win

Feb 14, 2024 9:10am

Takeda HQ

Takeda pledges some $765M for plasma-derived therapy plant in Japan

Mar 23, 2023 5:09pm